Literature DB >> 35410853

Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Keyvan Heydari1, Mohammad Yousefi2, Reza Alizadeh-Navaei3, Parisa Lotfi4, Fateme Sheydaee2, Maedeh Raei5, Alireza Vahdatinia4, Amirhossein Hessami4, Sajjad Rafati4, Mahmood Moosazadeh3, Roya Ghasemian6, Fatemeh Salehi7, Haleh Massoudi8, Fatemeh Ghaffari-Saravi9, Sahar Rismantab8.   

Abstract

Since numerous studies have stated that there may be a relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease, and because of the high prevalence of both conditions worldwide, this study investigated the risk of non-alcoholic fatty liver disease in patients infected with H. pylori. Following a systematic review of PubMed, Scopus, Web of Science and Embase, and a search in Google Scholar using MeSH terms such as H. pylori and non-alcoholic fatty liver disease, the relevant papers up to November 2020 were reviewed. All cohort, case-control, and cross-sectional studies that examined the risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori entered this study. A meta-analysis was conducted in STATA 11. This systematic review examined 22 papers with 117 117 participants (33 711 patients infected with H. pylori and 83 406 participants as control) and 20 studies were subjected to meta-analysis The results indicated a 22% to 27% increase in the risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori (crude odds ratio: 1.27, 95% CI: 1.17-1.33; and adjusted odds ratio: 1.22, 95% CI: 1.09-1.35). According to the subgroup analysis, the study region, sample size, and the method of diagnosing H. pylori were the factors contributing to the high heterogeneity. The meta-analysis revealed the increased risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori. This indicates that H. pylori is a serious risk factor in patients susceptible to NAFLD.

Entities:  

Mesh:

Year:  2022        PMID: 35410853      PMCID: PMC9128487          DOI: 10.5152/tjg.2022.21467

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.555


  46 in total

1.  Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-β1-induced inflammatory signaling.

Authors:  Mi-Ran Ki; Moon-Jung Goo; Jin-Kyu Park; Il-Hwa Hong; Ae-Ri Ji; Seon-Young Han; Sang-Young You; Eun-Mi Lee; Ah-Young Kim; Sang-Joon Park; Hyun-Joo Lee; Shin-Yoon Kim; Kyu-Shik Jeong
Journal:  Lab Invest       Date:  2010-06-07       Impact factor: 5.662

Review 2.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 3.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Zobair Younossi; Frank Tacke; Marco Arrese; Barjesh Chander Sharma; Ibrahim Mostafa; Elisabetta Bugianesi; Vincent Wai-Sun Wong; Yusuf Yilmaz; Jacob George; Jiangao Fan; Miriam B Vos
Journal:  Hepatology       Date:  2019-06       Impact factor: 17.425

4.  A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.

Authors:  Tae Jun Kim; Dong Hyun Sinn; Yang Won Min; Hee Jung Son; Jae J Kim; Yoosoo Chang; Sun-Young Baek; Soo Hyun Ahn; Hyuk Lee; Seungho Ryu
Journal:  J Gastroenterol       Date:  2017-04-05       Impact factor: 7.527

5.  Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.

Authors:  Ben-Gang Zhou; Huai-Jie Yang; Wei Xu; Kai Wang; Peng Guo; Yao-Wei Ai
Journal:  Helicobacter       Date:  2019-03-25       Impact factor: 5.753

6.  Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.

Authors:  Myong Ki Baeg; Seung Kew Yoon; Sun-Hye Ko; Yong-Sun Noh; In-Seok Lee; Myung-Gyu Choi
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

8.  Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Walaa Shabana; Mohamed Refaey; Rania Elhelaly; Rasha Elzehery; Mostafa Abdelsalam; Ayman Elgamal; Mervat R Nassar; Atef Abu El-Soud; Ahmed S Seif; Ahmed M Tawfik; Niveen El-Wakeel; Waleed Eldars
Journal:  Helicobacter       Date:  2018-09-23       Impact factor: 5.753

9.  The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial.

Authors:  Raika Jamali; Alireza Mofid; Homayoon Vahedi; Rojin Farzaneh; Shahab Dowlatshahi
Journal:  Hepat Mon       Date:  2013-12-06       Impact factor: 0.660

10.  Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.

Authors:  Lo-Yip Yu; Kuang-Chun Hu; Chun-Jen Liu; Chung-Lieh Hung; Ming-Jong Bair; Ming-Jen Chen; Horng-Yuan Wang; Ming-Shiang Wu; Shou-Chuan Shih; Chuan-Chuan Liu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.